Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in Pseudomonas aeruginosa
Top Cited Papers
- 1 December 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (12), 3322-3327
- https://doi.org/10.1128/aac.44.12.3322-3327.2000
Abstract
To find the exact substrate specificities of three species of tripartite efflux systems of Pseudomonas aeruginosa , MexAB-OprM, MexCD-OprJ, and MexXY-OprM, we constructed a series of isogenic mutants, each of which constitutively overproduced one of the three efflux systems and lacked the other two, and their isogenic mutants, which lacked all these systems. Comparison of the susceptibilities of the constructed mutants to 52 antimicrobial agents belonging to various groups suggested the following substrate specificities. All of the efflux systems extrude a wide variety of antimicrobial agent groups, i.e., quinolones, macrolides, tetracyclines, lincomycin, chloramphenicol, most penicillins (all but carbenicillin and sulbenicillin), most cephems (all but cefsulodin and ceftazidime), meropenem, and S-4661, but none of them extrude polymyxin B or imipenem. Extrusion of aminoglycosides is specific to MexXY-OprM, and extrusion of a group of the β-lactams, i.e., carbenicillin, sulbenicillin, ceftazidime, moxalactam, and aztreonam, is specific to MexAB-OprM. Moreover, MexAB-OprM and MexCD-OprJ extrude novobiocin, cefsulodin, and flomoxef, while MexXY-OprM does not. These substrate specificities are distinct from those reported previously.Keywords
This publication has 26 references indexed in Scilit:
- Subunit Swapping in the Mex-Extrusion Pumps inPseudomonas aeruginosaBiochemical and Biophysical Research Communications, 1998
- The Role ofmex-Gene Products in Antibiotic Extrusion inPseudomonas aeruginosaBiochemical and Biophysical Research Communications, 1997
- Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosaMolecular Microbiology, 1997
- Overexpression of the mexC–mexD–oprJ efflux operon in nfxB‐type multidrug‐resistant strains of Pseudomonas aeruginosaMolecular Microbiology, 1996
- A Novel 1.BETA.-Methylcarbapenem Antibiotic, S-4661.Synthesis and Structure-activity Relationships of 2-(5-Substituted Pyrrolidin-3-ylthio)-1.BETA.-methylcarbapenems.The Journal of Antibiotics, 1996
- Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1992
- Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid mediaAntimicrobial Agents and Chemotherapy, 1991
- A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative BacteriaBio/Technology, 1983